No Data
No Data
Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals
WOBURN, MA / ACCESSWIRE / March 26, 2024 / Biofrontera, Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological products, today announce
Biofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call Transcript
Analysts' Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)
Q4 2023 Biofrontera Inc Earnings Call
Earnings Call: Biofrontera Posts Record Revenue and Outlines Growth Plans
Earnings Call Summary | Biofrontera(BFRI.US) Q4 2023 Earnings Conference
The following is a summary of the Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript:Financial Performance:Q4 and total 2023 revenue was $10.6 million and $34.1 million respectively, an increase
No Data